Protalix BioTherapeutics
PLX
#8349
Rank
ยฃ0.16 B
Marketcap
ยฃ2.10
Share price
6.11%
Change (1 day)
1.65%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): ยฃ0.01352

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.01464. In 2024 the company made an earnings per share (EPS) of ยฃ0.02928 a decrease over its 2023 EPS that were of ยฃ0.08783.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ0.01352-53.81%
2024ยฃ0.02928-66.67%
2023ยฃ0.08783-138.71%
2022-ยฃ0.23-50%
2021-ยฃ0.45181.82%
2020-ยฃ0.16-82.11%
2019-ยฃ0.90-31.67%
2018-ยฃ1.32-72.31%
2017-ยฃ4.76124.14%
2016-ยฃ2.12-147.54%
2015ยฃ4.46-290.63%
2014-ยฃ2.346.67%
2013-ยฃ2.20130.77%
2012-ยฃ0.95-69.77%
2011-ยฃ3.1519.44%
2010-ยฃ2.63-12.2%
2009-ยฃ3.0036.67%
2008-ยฃ2.20-37.5%
2007-ยฃ3.5150%
2006-ยฃ2.343.23%
2005-ยฃ2.27138.46%
2004-ยฃ0.95-74%
2003-ยฃ3.66-0%
2002-ยฃ3.66-50%
2001-ยฃ7.32233.33%
2000-ยฃ2.20-84.21%
1999-ยฃ13.91-24%
1998-ยฃ18.30-600%
1997ยฃ3.66-16.67%
1996ยฃ4.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ1.00 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ3.15 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-ยฃ0.08051-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.91 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel